Dynamic Models of Infectious Disease Transmission in Prisons and the General Population.

Martial L Ndeffo-Mbah, Vivian S Vigliotti, Laura A Skrip, Kate Dolan, Alison P Galvani
Author Information
  1. Martial L Ndeffo-Mbah: Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, Yale University, New Haven, Connecticut.
  2. Vivian S Vigliotti: Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, Yale University, New Haven, Connecticut.
  3. Laura A Skrip: Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, Yale University, New Haven, Connecticut.
  4. Kate Dolan: Program of International Research and Training, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia.
  5. Alison P Galvani: Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, Yale University, New Haven, Connecticut.

Abstract

Incarcerated populations experience elevated burdens of infectious diseases, which are exacerbated by limited access to prevention measures. Dynamic models are used to assess the spread and control of diseases within correctional facilities and repercussions on the general population. Our systematic review of dynamic models of infectious diseases within correctional settings identified 34 studies published between 1996 and 2017. Of these, 23 focused on disease dynamics and intervention in prison without accounting for subsequent spread to the community. The main diseases modeled in these studies were human immunodeficiency virus (HIV; n = 14, 41%), tuberculosis (TB; n = 10, 29%), and hepatitis C virus (HCV; n = 7, 21%). Models were fitted to epidemiologic data in 14 studies; uncertainty and sensitivity analyses were conducted in 8, and validation of model projection against empirical data was done in 1 study. According to the models, prison-based screening and treatment may be highly effective strategies for reducing the burden of HIV, TB, HCV, and other sexually transmissible infections among prisoners and the general community. Decreasing incarceration rates were projected to reduce HIV and HCV infections among people who inject drugs and TB infections among all prisoners. Limitations of the modeling studies and opportunities for using dynamic models to develop quantitative evidence for informing prison infection control measures are discussed.

References

  1. Appl Occup Environ Hyg. 1999 Nov;14(11):768-76 [PMID: 10590550]
  2. Addiction. 2017 Jul;112(7):1302-1314 [PMID: 28257600]
  3. Health Econ. 2010 May;19(5):518-31 [PMID: 19382106]
  4. Clin Infect Dis. 2009 Jan 1;48(1):72-82 [PMID: 19046064]
  5. Nat Rev Microbiol. 2007 Sep;5(9):700-9 [PMID: 17703226]
  6. Med Decis Making. 2012 May-Jun;32(3):442-6 [PMID: 22472916]
  7. Value Health. 2012 Sep-Oct;15(6):828-34 [PMID: 22999132]
  8. Public Health. 2006 Jan;120(1):33-41 [PMID: 16129465]
  9. Health Educ Behav. 1998 Feb;25(1):99-120 [PMID: 9474502]
  10. Sex Transm Dis. 2013 Oct;40(10):776-83 [PMID: 24275727]
  11. Lancet. 2016 Sep 10;388(10049):1089-1102 [PMID: 27427453]
  12. BMC Infect Dis. 2013 Jun 28;13:294 [PMID: 23809195]
  13. BMJ Open. 2013 Aug 13;3(8):null [PMID: 23943776]
  14. PLoS Med. 2010 Dec 21;7(12):e1000381 [PMID: 21203587]
  15. Nat Rev Gastroenterol Hepatol. 2017 Feb;14 (2):122-132 [PMID: 27924080]
  16. Lancet. 2016 Dec 10;388(10062):2870 [PMID: 27979404]
  17. PLoS Med. 2012;9(11):e1001348 [PMID: 23209384]
  18. IMA J Math Appl Med Biol. 1996 Dec;13(4):223-44 [PMID: 8968784]
  19. Vaccine. 2013 Jun 26;31(30):3079-89 [PMID: 23684837]
  20. Drug Alcohol Depend. 1998 May 1;50(3):197-202 [PMID: 9649972]
  21. Lancet. 2016 Sep 17;388(10050):1228-48 [PMID: 27427455]
  22. Comput Math Methods Med. 2013;2013:648291 [PMID: 23762194]
  23. Lancet Infect Dis. 2009 Jan;9(1):57-66 [PMID: 19095196]
  24. Am J Epidemiol. 2013 Mar 1;177(5):463-73 [PMID: 23403986]
  25. Lancet. 2016 Sep 10;388(10049):1103-1114 [PMID: 27427452]
  26. PLoS One. 2015 May 15;10(5):e0128734 [PMID: 25978721]
  27. BMJ Open. 2012 Oct 18;2(5):null [PMID: 23087014]
  28. PLoS One. 2008 May 07;3(5):e2100 [PMID: 18461123]
  29. Prison J. 2007;87(3):295-310 [PMID: 18584061]
  30. Ann Intern Med. 2016 Jan 19;164(2):84-92 [PMID: 26595252]
  31. Rev Saude Publica. 2000 Oct;34(5):431-6 [PMID: 11105105]
  32. Clin Infect Dis. 2007 Oct 15;45(8):1047-55 [PMID: 17879924]
  33. Addiction. 2006 Feb;101(2):181-91 [PMID: 16445547]
  34. S Afr Med J. 2011 Nov 01;101(11):809-13 [PMID: 22272961]
  35. Emerg Infect Dis. 2015 Mar;21(3):452-5 [PMID: 25642998]
  36. Lancet. 2015 Oct 17;386(10003):1546-55 [PMID: 26231459]
  37. Hepatology. 2016 Jun;63(6):1796-808 [PMID: 26864802]
  38. Am J Trop Med Hyg. 2011 Jan;84(1):30-7 [PMID: 21212197]
  39. BMC Public Health. 2010 Oct 22;10:633 [PMID: 20964864]
  40. Am J Epidemiol. 2016 Mar 1;183(5):415-22 [PMID: 26893297]
  41. Lancet. 2013 Nov 9;382(9904):1564-74 [PMID: 23993281]
  42. PLoS One. 2016 Sep 30;11(9):e0163880 [PMID: 27690247]
  43. PLoS One. 2015 Dec 14;10(12):e0144869 [PMID: 26658518]
  44. Sex Transm Dis. 2009 Feb;36(2 Suppl):S41-8 [PMID: 18303352]
  45. Lancet. 2016 Sep 10;388(10049):1115-1126 [PMID: 27427456]
  46. Lancet. 2017 Apr 8;389(10077):1464-1474 [PMID: 28402828]
  47. Am J Trop Med Hyg. 2015 Oct;93(4):739-46 [PMID: 26195459]
  48. Lancet. 2011 Aug 6;378(9790):515-25 [PMID: 21481448]
  49. Value Health. 2012 Sep-Oct;15(6):843-50 [PMID: 22999134]
  50. Pharmacoeconomics. 2011 May;29(5):371-86 [PMID: 21504239]
  51. Vaccine. 2006 Mar 20;24(13):2377-86 [PMID: 16384627]
  52. Am J Public Health. 2002 Nov;92(11):1789-94 [PMID: 12406810]
  53. Infect Dis Model. 2016 Jun 21;1(1):11-27 [PMID: 29928718]

Grants

  1. R01 AI151176/NIAID NIH HHS
  2. U01 GM087719/NIGMS NIH HHS
  3. U01 GM105627/NIGMS NIH HHS

MeSH Term

Communicable Disease Control
Communicable Diseases
Disease Transmission, Infectious
Global Health
Humans
Models, Biological
Prisoners
Prisons

Word Cloud

Created with Highcharts 10.0.0diseasesmodelsstudiesHIVn=TBHCVinfectionsamonginfectiousmeasuresDynamicspreadcontrolwithincorrectionalgeneraldynamicprisoncommunityvirus14ModelsdataprisonersIncarceratedpopulationsexperienceelevatedburdensexacerbatedlimitedaccesspreventionusedassessfacilitiesrepercussionspopulationsystematicreviewsettingsidentified34published1996201723focuseddiseasedynamicsinterventionwithoutaccountingsubsequentmainmodeledhumanimmunodeficiency41%tuberculosis1029%hepatitisC721%fittedepidemiologicuncertaintysensitivityanalysesconducted8validationmodelprojectionempiricaldone1studyAccordingprison-basedscreeningtreatmentmayhighlyeffectivestrategiesreducingburdensexuallytransmissibleDecreasingincarcerationratesprojectedreducepeopleinjectdrugsLimitationsmodelingopportunitiesusingdevelopquantitativeevidenceinforminginfectiondiscussedInfectiousDiseaseTransmissionPrisonsGeneralPopulation

Similar Articles

Cited By